Study Stopped
The study was cancelled due to change in food registration regulations in China.
Improving Nutritional Status With Oral Nutritional Supplement in Chinese Elderly
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
This is a single- country, interventional, double-arm study involving Chinese Elderly subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2015
CompletedFirst Posted
Study publicly available on registry
February 11, 2015
CompletedStudy Start
First participant enrolled
October 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedDecember 2, 2016
November 1, 2016
9 months
January 27, 2015
November 30, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Change of body weight from baseline to the end of the study
24 weeks
Secondary Outcomes (1)
Total number of sick days due to Upper Respiratory Tract Infections (URTI)
24 weeks
Study Arms (2)
Oral Nutritional Supplement
EXPERIMENTALONS + Nutritional education
Control Group
OTHERNutritional education only
Interventions
Will receive ONS twice a day for 6 months and two nutritional education at baseline and 3 months after intervention
Two nutritional education courses at baseline and 3 months after intervention
Eligibility Criteria
You may qualify if:
- Male or female Chinese ages \>= 60 years.
- Subject is ambulatory.
- Subject with risks of malnutrition defined as DETERMINE score \>=3
- Subject's BMI is below 28.
- Subject has experienced hospital stay or surgery within 6 months prior to enrollment;
- Subject if takes any medications for concomitant chronic diseases should be in stable dosage for at least 3 weeks.
- Subject plans to live in the community for more than 6 months after recruitment.
- Subject has voluntarily signed and dated an informed consent form, approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) prior to any participation in the study.
You may not qualify if:
- Subject has history of allergy to any ingredient in the study product
- Subject dislikes the experimental product
- Subject has been diagnosed with diabetes.
- Subject who has malignancy expected to receive chemotherapy/ radiotherapy scheduled during the study period,
- Subject has a life expectancy less than 6 months.
- Subject who has reported chronic liver disease or liver cirrhosis or liver failure or any liver diseases not suitable for the study as the study physician's opinion.
- Subject who has reported impacted renal function as eGFR \< 30 mL/min/1.73 m2 or renal dysfunction severe greater than stage 4 or any other renal diseases not suitable for the study as the study physician' s opinion.
- Subject who has experienced fever or diarrhea within one week prior to enrollment.
- Subject who is expected to have scheduled major surgery during the study period.
- Subject who has physical disabilities such as loss of hand or foot or limbs or any other physical disability which may affect the muscle mass measurement by the opinion of the study physician.
- Subject has an implanted electronic device or orthopedic metal implantations, such as pacemaker, cardiac defibrillator, subcutaneous injection pump, or metal hip, metal knee joint, metal fracture internal fixation, etc.
- Subject who has active tuberculosis (TB), hepatitis, or HIV infection as self-reported at enrollment.
- Subject has severe dementia or delirium, brain metastases, eating disorder, history of significant neurological or psychiatric disorder, or other conditions that may interfere with study product consumption or compliance with study protocol procedures in the opinion of the principal investigator or study physician.
- Subject is drug addicted or alcohol addicted
- Subject has any other disease or situation who should not to participate in the study by the opinion of study physicians.
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abbott Nutritionlead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Xianfeng ZHAO, MD, PhD
Abbott Nutrition R&D China
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 27, 2015
First Posted
February 11, 2015
Study Start
October 1, 2016
Primary Completion
July 1, 2017
Study Completion
December 1, 2017
Last Updated
December 2, 2016
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will not share